Sean Zhang, MD, FCP

CEO of Hengrui Therapeutics​

Dr. Sean Zhang is a well accredited Physician-Scientist with more than 30 years’ experience in medical practice, academic research, drug discovery and development. He has ~20-years of pharmaceutical industry work experience in global leading pharmaceutical companies such as Merck, Johnson & Johnson, Bristol-Myers Squibb and GlaxoSmithKline with increasing responsibilities. His extensive experience spans the entire drug discovery, clinical development and life cycle management process.

Before coming to the United States, Dr. Zhang was a Staff Physician and Clinical Investigator in the Chinese Military General (301) Hospital in Beijing, China with a focus on the early diagnosis and treatment of gastrointestinal and liver cancers. He completed his clinical fellowship training program in Clinical Pharmacology at the Clinical Center of National Institute of Health after passing the United States Medical License Examination. Dr. Zhang is a Fellow of American College of Clinical Pharmacology (FCP), and a board member of the Sino-American Pharmaceutical Professional Association (SAPA), an organization with more than five thousand Chinese American pharmaceutical professionals. He has authored more than 30 peer-reviewed publications and is a frequent speaker at multiple national/international conferences/symposiums on translational medicine and early drug development.